Australia's most trusted
source of pharma news
Friday, 18 October 2024
Friday, 18 October 2024
Subscribe
Login
News Headlines
News Headlines
News
J&J celebrates new highest earner
Posted 17 October 2024 AM
Johnson & Johnson has reported solid growth in the third quarter, with a surging Darzalex boosting the oncology portfolio, compensating for wilting immunology sales.
The pharma giant saw global revenues for innovative medicine for the third quarter this year increase 4.9 per cent year-on-year, adding $1.027 billion (US$687 million) to hit $21.79 billion (US$14.580 billion). The main driver was the oncology portfolio, which added US$847 to contribute US$5.380 billion to the total.
To see the whole article, please login
Posted 17 October 2024 AM
Johnson & Johnson has reported solid growth in the third quarter, with a surging Darzalex boosting the oncology portfolio, compensating for wilting immunology sales.
The pharma giant saw global revenues for innovative medicine for the third quarter this year increase 4.9 per cent year-on-year, adding $1.027 billion (US$687 million) to hit $21.79 billion (US$14.580 billion). The main driver was the oncology portfolio, which added US$847 to contribute US$5.380 billion to the total.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (17)
- Account Manager - Chatswood
- Account Manager - Brisbane
- Hospital Specialist Representative - Sydney
- Clinical Account Manager - Perth
- Customer Service Representative - Macquarie Park
- Territory Manager - Newcastle
- Medical Representative - Melbourne
- Customer Service & Supply Chain Associate - Botany
- Customer Service Representative - St Leonards
- Key Account Manager - Melbourne
- Specialist, Oncology Hospital Sales - NSW
- Specialist, Oncology Hospital Sales - Victoria - VIC
- Assistant Accountant - Melbourne
- Hospital Specialist Representative - Brisbane
- Territory Manager - Capital Equipment - Melbourne
- Medical Sales Representative - New South Wales
- GP Sales Representative - Brisbane
Access & Reimbursement (1)
Clinical & Medical, R&D (18)
- Senior Scientist - Diagnostics - Clayton
- Clinical Specialist - Brisbane
- Clinical Account Manager - Perth
- Medical Recruitment Consultant - Sydney
- Medical Representative - Melbourne
- Medical Advisor - Sydney
- Clinical Trials Coordinator - Queensland
- Clinical Trials Coordinator - Sunshine Coast
- Clinical Nurse Educator - Sydney
- Medical Science Liaison, Ophthalmolgy - QLD
- Medical Science Liaison, Oncology - QLD
- Clinical Research Nurse - Melbourne
- Senior Preclinical Development Scientist - 12 month contract - Sydney
- Quality Control Microbiologist - Melbourne
- Clinical Site Director - Melbourne
- Clinical Trials Coordinator - Melbourne
- Medical Affairs Associate - Sydney
- Medical Sales Representative - New South Wales
Regulatory, Pharmacovigilance & QA (7)
- Quality Assurance Complaints Associate - Sydney
- Quality System Specialist/Technical Writer - Tullamarine
- Quality Control Microbiologist - Melbourne
- Quality Control Chemistry Analyst (Stores) - Parkville
- RA/QA Specialist - Sydney
- Quality Control Virology Analyst - Parkville
- Regulatory Affairs Manager - Sydney
Other (16)
- Senior PV Associate - Sydney
- Pricing Specialist - Macquarie Park
- Storeperson - Toongabbie
- Warehouse Assistant - Macquarie Park
- Logistics Operator - Tullamarine
- Recruitment Consultant - Sydney
- Warehouse Storeman/Forklift Driver - Broadmeadows
- Storeperson - Macquarie Park
- HSR - Rare Disease NSW & ACT - Sydney
- Supply Chain Coordinator - Macquarie Park
- Pharmacy Assistant - Brunswick
- Lead, Therapeutic Area Specialty, Women's Health - Australia
- Principal Investigator - Melbourne
- Supply Chain Associate - Macquarie Park
- Principle Investigator - Sydney
- Material Planner / Inventory Coordinator - Tullamarine
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.